ReviewFrontiers in medicine2024

Treatment intensification with radium-223 plus enzalutamide in patients with metastatic castration-resistant prostate cancer.

Neal Shore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.